Camina Medical at Future Labs Live 2026

Camina Medical at Future Labs Live 2026: Driving Innovation in Clinical Research

Camina Medical Experts is proud to announce that our Chief Executive Officer, Dr Cristina Florescu Moraid, attended the prestigious Future Labs Live 2026 conference, held at the Congress Center Basel, Switzerland, from 27 to 28 May 2026.

As Europe’s leading event for laboratory innovation, the two-day summit united over 3,000 visionaries, technology pioneers, and C-level executives. Key discussions centred on the next generation of life sciences, focusing on artificial intelligence (AI), automation, robotics, digital transformation, and sustainable laboratory ecosystems.

Pioneering the Connected and Digital Lab

For Camina Medical Experts, remaining at the forefront of clinical research technology is vital to streamlining workflows and delivering exceptional clinical trial solutions. Dr Florescu Moraid’s participation underlines our commitment to adopting advancements in laboratory data management and automation.

The 2026 agenda highlighted a critical transition within industry standards, moving from "Raw-to-Ready" data frameworks to establish the essential foundations for practical AI implementation. For a specialised service provider like Camina Medical Experts, implementing high-quality, AI-ready data practices ensures maximum precision, reduced operational risks, and accelerated clinical decision-making.

Aligning Innovation with Patient-Centric Research

A major takeaway from Future Labs Live 2026 was the critical focus on cross-industry connectivity and more sustainable ways of working. These insights align seamlessly with Camina Medical’s core ethos of integrating digital innovation with a dedicated patient-first approach.

"Innovation is only as powerful as the lives it transforms." — Dr Cristina Florescu Moraid

By exploring the latest benchtop liquid handling systems, robotics, and advanced scientific knowledge management systems, Camina Medical continues to enhance how decentralised clinical trials (DCTs) are managed. Seamless laboratory automation translates directly to improved patient safety, greater trial flexibility, and more reliable data delivery for pharma sponsors and biotech organisations worldwide.

Looking to the Future

The strategies discussed in Basel will directly inform Camina Medical's service development moving through 2026. By bridging the gap between cutting-edge laboratory breakthroughs and real-world clinical applications, we continue to deliver tailored, premium clinical trial solutions that shape the future of global medicine.